Strategic Pharmaceutical Advisors (SRxA) launches Strategic Respiratory Advisors – Europe

Strategic Pharmaceutical Advisors (SRxA), a leading U.S. healthcare strategic marketing consulting and education firm proudly announced the formation of its European affiliate Strategic Respiratory Advisors – Europe (SRxA–Europe).
By: Christos S. Efessiou, PhD
 
Sept. 6, 2008 - PRLog -- SRxA-Europe will be led by G. Walter Canonica, MD, of Genoa University, Genoa, Italy and President of the World Allergy Organization;  Jean Bousquet, MD, of the University of Montpellier, Montpellier, France; Sergio Bonini, MD , Second University of Naples and INMM-CNR, ARTOV, Rome, Italy, and Stephen Holgate, MD, of Southampton University School of Medicine, Southampton, United Kingdom.

These experts will work closely with their American counterparts which include Michael A. Kaliner, MD, William W. Storms, MD, Bradley Chipps, MD, Allan Luskin, MD, Sheldon Spector, MD, John Oppenheimer, MD, Peter Dicpinigaitis, MD, Don Bukstein, MD, Michael Benninger, MD, Jennifer Derebery, MD, Bradley Marple, MD, James Hadley, MD and others, to provide clients with access to the highest echelon of Respiratory Thought Leaders worldwide.

“Since its inception, SRxA has successfully assisted pharmaceutical companies with educational, clinical, regulatory, and marketing support programs in the United States. The newest affiliate represents a key step in the growth of our services designed to address the needs of our pharmaceutical clients globally” said Christos Efessiou, SRxA’s Chief Executive Officer commenting on the planned expansion of the company.

SRxA operates on a unique business model that utilizes clinical teams of national and international experts who partner with experts in industry and communications to provide the latest information and education in allergy, asthma, immunology, pulmonary diseases, and otolaryngology.  

Other SRxA affiliates operating in the United States include Strategic Allergy Advisors (SAA), Strategic Pulmonary Advisors (SPA), and Strategic Ear, Nose and Throat Advisors (SENTA).  The company plans to introduce new affiliates in other key specialties in the near future.

SRxA is headquartered in Washington, DC with offices in London and Hong Kong.

# # #

Strategic Pharmaceutical Advisors (SRxA), a leading U.S. healthcare strategic marketing consulting and education firm, is a network of experts in specific therapeutic areas. SRxA is headquartered in Washington, DC with offices in London and Hong Kong.
End
Strategic Pharmaceutical Advisors News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share